Related Experiment Video
Updated: Aug 11, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Efficacy of epsilon-aminocaproic acid in children undergoing cardiac surgery
G D Williams1, S L Bratton, E C Riley
1Department of Anesthesiology, University of Washington School of Medicine, Seattle, USA.
Insights
Epsilon-aminocaproic acid (EACA) reduced intraoperative blood loss in pediatric cardiac surgery patients but did not significantly decrease blood product transfusions. Further studies are needed to explore optimal dosing for efficacy.
Area of Science:
- Cardiology
- Anesthesiology
- Pediatric Surgery
Background:
- Bleeding is a significant complication in pediatric cardiac surgery.
- Prophylactic antifibrinolytic agents like epsilon-aminocaproic acid (EACA) are used to reduce blood loss.
- Optimal EACA dosing in pediatric cardiac surgery remains under investigation.
Purpose of the Study:
- To compare coagulation test results, blood loss, and blood product transfusions between children receiving prophylactic EACA and a control group.
- To evaluate the efficacy of EACA in reducing bleeding complications during pediatric cardiac surgery.
Main Methods:
- A nested case-control study was conducted at a pediatric medical center.
- 70 patients receiving prophylactic EACA were matched with 70 control patients.
- EACA was administered intravenously (load and infusion) to patients at increased risk for bleeding.
Main Results:
- The EACA group showed significantly less intraoperative blood loss (p = 0.02).
- No significant differences were observed in postoperative chest tube output between groups.
- Fewer patients in the EACA group required reexploration for bleeding (p < 0.05), and coagulation parameters were better preserved.
Conclusions:
- EACA effectively reduced intraoperative blood loss in pediatric cardiac surgery.
- EACA did not significantly decrease blood product transfusions, possibly due to underdosing.
- Further research is warranted to determine optimal EACA dosing strategies for improved efficacy.
Objective:
To compare coagulation test results, blood loss, and blood product transfusions between patients receiving prophylactic epsilon-aminocaproic acid (EACA) and a control group matched for age, resternotomy, and surgery in children undergoing cardiac surgery.
Design:
Nested case-control study.
Setting:
University-affiliated, pediatric medical center.
Participants:
Same study period; 70 patients in EACA group and 70 patients in control group.
Interventions:
Prophylactic EACA administered intravenously (load, 150 mg/kg, infusion; 30 mg/kg/h) to 70 patients at increased risk for bleeding (reoperation or Ross procedure).
Measurements And Main Results:
Coagulation test values were measured before, during, and after cardiopulmonary bypass (CPB). Intraoperative blood loss, postoperative chest tube output, and allogenic blood product transfusions were recorded. Comparison of demographic and surgical data indicated close matching of the EACA and control groups. The EACA group ([median, 25th to 75th quartile] 15.6 mL/kg; 9.2 to 26.3 mL/kg) had less intraoperative blood loss than the control group (22.2 mL/kg; 14.3 to 36.3 mL/kg; p = 0.02). Postoperative chest tube output at 6 hours (p = 0.08), 12 hours (p = 0.07), and 24 hours (p = 0.08) was not significantly different between groups. Fewer EACA group patients required reexploration for bleeding (p < 0.05). There was no difference between groups in blood products transfused (in milliliters per kilogram or allogenic exposure per patient). Thromboelastography values (maximum amplitude [MA], whole blood clot lysis index at 30 minutes after MA) during CPB were better preserved in the EACA group.
Conclusion:
EACA reduced intraoperative blood loss but did not significantly decrease blood product transfusions. Lack of efficacy may be related to relative underdosing and should be further studied.
Related Concept Videos
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
Aneurysm IV: Nursing Management

